What is he best known for?
The fields of study he is best known for:
- Enzyme
- Amino acid
- Biochemistry
His scientific interests lie mostly in Enkephalin, Opioid, Agonist, Pharmacology and δ-opioid receptor.
His studies in Enkephalin integrate themes in fields like -Naloxone and Endocrinology.
His Agonist study is related to the wider topic of Receptor.
His research in Receptor intersects with topics in Pharmacophore, Stereochemistry and Analgesic.
His biological study spans a wide range of topics, including Naltrindole and Etorphine.
His Morphine study combines topics from a wide range of disciplines, such as Mechanism of action, Antagonist and Nociception.
His most cited work include:
- OPM: Orientations of Proteins in Membranes database (863 citations)
- OPM database and PPM web server: resources for positioning of proteins in membranes (718 citations)
- Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. (624 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Stereochemistry, Pharmacology, Agonist, Receptor and Enkephalin.
His Stereochemistry research is multidisciplinary, relying on both Ligand, Cyclic peptide, Tetrapeptide, Peptide and Opioid receptor.
His Pharmacology research incorporates elements of Antagonist, Potency, Opioid and Nociception.
Within one scientific family, Henry I. Mosberg focuses on topics pertaining to Endocrinology under Agonist, and may sometimes address concerns connected to Naltrindole.
His Receptor study is focused on Biochemistry in general.
The Enkephalin study combines topics in areas such as -Naloxone, δ-opioid receptor and Mechanism of action.
He most often published in these fields:
- Stereochemistry (38.10%)
- Pharmacology (31.43%)
- Agonist (30.48%)
What were the highlights of his more recent work (between 2011-2021)?
- Agonist (30.48%)
- Pharmacology (31.43%)
- Opioid receptor (18.57%)
In recent papers he was focusing on the following fields of study:
His main research concerns Agonist, Pharmacology, Opioid receptor, Opioid and Antagonist.
Henry I. Mosberg does research in Agonist, focusing on μ-opioid receptor specifically.
The study incorporates disciplines such as Receptor, δ-opioid receptor and Opioid peptide in addition to Pharmacology.
His Receptor research is under the purview of Biochemistry.
His research in Opioid intersects with topics in Peptidomimetic and Structure–activity relationship.
His biological study spans a wide range of topics, including Morphine, Conditioned place preference, In vivo, Drug tolerance and Peptide.
Between 2011 and 2021, his most popular works were:
- OPM database and PPM web server: resources for positioning of proteins in membranes (718 citations)
- Structural adaptations of proteins to different biological membranes (42 citations)
- Opioid peptidomimetics: leads for the design of bioavailable mixed efficacy μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands. (32 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Amino acid
- Biochemistry
Henry I. Mosberg mainly investigates Opioid receptor, Agonist, Pharmacology, Antagonist and Opioid.
Henry I. Mosberg studies Pharmacology, focusing on Morphine in particular.
His Morphine research is multidisciplinary, relying on both Drug tolerance and Peptide.
His Antagonist study which covers In vivo that intersects with Stereochemistry, Physical dependence, Conditioned place preference and Naltrexone.
His Stereochemistry study integrates concerns from other disciplines, such as Combinatorial chemistry and In vitro.
Opioid is a subfield of Receptor that Henry I. Mosberg tackles.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
